Activation of the PI3K pathway is very common in GBM [3] due to amplification or mutation in EGFR or other receptor tyrosine kinases, such as PI3K, PIK3CA, PTEN and NF1 [2, 3]. The gene discussed is NF1; the disease is glioblastoma.